Appetite regulation: From the gut to the hypothalamus

Clinical Endocrinology

Volumn 60, Issue 2, 2004, Pages 153-160

  Neary, Nicola Marguerite ^a   Goldstone, Anthony Peter ^b   Bloom, Stephen Robert ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGOUTI RELATED PROTEIN; ALPHA INTERMEDIN; ANTIOBESITY AGENT; APPETITE STIMULANT; CHOLECYSTOKININ; DEXFENFLURAMINE; FENFLURAMINE; GHRELIN; GLUCAGON LIKE PEPTIDE; GROWTH HORMONE SECRETAGOGUE RECEPTOR; HORMONE; INSULIN; LEPTIN; MELANOCORTIN; MELANOCORTIN RECEPTOR; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; NORADRENALIN; NORADRENALIN UPTAKE INHIBITOR; PEPTIDE YY; PLACEBO; RECOMBINANT LEPTIN; SEROTONIN; SEROTONIN 2C ANTAGONIST; SEROTONIN 2C RECEPTOR; SEROTONIN AGONIST; SEROTONIN UPTAKE INHIBITOR; SIBUTRAMINE; TETRAHYDROLIPSTATIN;

ANOREXIA; APPETITE; BODY FAT; BODY MASS; BODY WEIGHT; BRAIN FUNCTION; BRAIN STEM; CACHEXIA; CALORIC INTAKE; CLINICAL TRIAL; DIET RESTRICTION; DRUG POTENCY; DRUG POTENTIATION; DRUG SAFETY; DRUG TOLERABILITY; DRUG USE; ELECTROLYTE DISTURBANCE; ENDOCRINE SYSTEM; ENTERITIS; EXERCISE; FECES; FEEDING BEHAVIOR; FLATULENCE; FOOD INTAKE; HUMAN; HYPERPHAGIA; HYPERTENSION; HYPOTHALAMUS; INJECTION; INSULIN RELEASE; INTERMETHOD COMPARISON; INTESTINE; JEJUNOILEAL BYPASS; LIPID ABSORPTION; LIVER FAILURE; MALABSORPTION; NEPHROLITHIASIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OSTEOMALACIA; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN FAMILY; PULSE RATE; REGULATORY MECHANISM; REVIEW; ROUX Y ANASTOMOSIS; SEROTONIN RELEASE; SIDE EFFECT; STOMACH BYPASS; SURGICAL TECHNIQUE; VALVULAR HEART DISEASE; WEIGHT REDUCTION;

ADIPOSE TISSUE; ANIMALS; APPETITE REGULATION; BRAIN STEM; FEMALE; HUMANS; HYPOTHALAMUS; INSULIN; INTESTINES; LEPTIN; MALE; NEUROPEPTIDES; OBESITY; PEPTIDE HORMONES;

EID: 1042288138     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2003.01839.x     Document Type: Review

References (59)

1. Ahima, R.S., Prabakaran, D., Mantzoros, C., Qu, D., Lowell, B., Maratos-Flier, E. & Flier, J.S. (1996) Role of leptin in the neuroendocrine response to fasting. Nature, 382, 250-252.
2. Ahren, B., Simonsson, E., Larsson, H., Landin-Olsson, M., Torgeirsson, H., Jansson, P.A., Sandqvist, M., Bavenholm, P., Efendic, S., Eriksson, J.W., Dickinson, S. & Holmes, D. (2002) Inhibition of dipeptidyl peptidase IV improves metabolic control over a 4-week study period in type 2 diabetes. Diabetes Care, 25, 869-875.
3. Atkinson, R.L. & Brent, E.L. (1982) Appetite suppressant activity in plasma of rats after intestinal bypass surgery. American Journal of Physiology, 243, R60-R64.
4. Batterham, R.L., Cowley, M.A., Small, C.J., Herzog, H., Cohen, M.A., Dakin, C.L., Wren, A.M., Brynes, A.E., Low, M.J., Ghatei, M.A., Cone, R.D. & Bloom, S.R. (2002) Gut hormone PYY (3-36) physiologically inhibits food intake. Nature, 418, 650-654.
5. Baura, G.D., Foster, D.M., Porte, D. Jr, Kahn, S.E., Bergman, R.N., Cobelli, C. & Schwartz, M.W. (1993) Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. A mechanism for regulated insulin delivery to the brain. Journal of Clinical Investigations, 92, 1824-1830.
6. Blundell, J.E. (1984) Serotonin and appetite. Neuropharmacology, 23, 1537-1551.
7. Chinn, S. & Rona, R.J. (2001) Prevalence and trends in overweight and obesity in three cross sectional studies of British children, 1974-1994. British Medical Journal, 322, 24-26.
8. Chua, S.C. Jr., Chung, W.K., Wu-Peng, X.S., Zhang, Y., Liu, S.M., Tartaglia, L. & Leibel, R.L. (1996) Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science, 271, 994-996.
9. Connolly, H.M., Crary, J.L., McGoon, M.D., Hensrud, D.D., Edwards, B.S., Edwards, W.D. & Schaff, H.Y. (1997) Valvular heart disease associated with fenfluramine-phentermine. New England Journal of Medicine, 337, 581-588.
10. Considine, R.V., Sinha, M.K., Heiman, M.L., Kriauciunas, A., Stephens, T.W., Nyce, M.R., Ohannesian, J.P., Marco, C.C., McKee, L.J. & Bauer, T.L. (1996) Serum immunoreactive-leptin concentrations in normal-weight and obese humans. New England Journal of Medicine, 334, 292-295.
11. Cowley, M.A., Smart, J.L., Rubinstein, M., Cerdan, M.G., Diano, S., Horvath, T.L., Cone, R.D. & Low, M.J. (2001) Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature, 411, 480-484.
12. Crawley, J.N. & Beinfeld, M.C. (1983) Rapid development of tolerance to the behavioural actions of cholecystokinin. Nature, 302, 703-706.
13. Cummings, D.E., Pumell, J.Q., Frayo, R.S., Schmidova, K., Wisse, B.E. & Weigle, D.S. (2001) A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes, 50, 1714-1719.
14. Cummings, D.E., Weigle, D.S., Frayo, R.S., Breen, P.A., Ma, M.K., Dellinger, E.P. & Purnell, J.Q. (2002) Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. New England Journal of Medicine, 346, 1623-1630.
15. Daling, J.R., Malone, K.E., Doody, D.R., Johnson, L.G., Gralow, J.R. & Porter, P.L. (2001) Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinoma. Cancer, 92, 720-729.
16. Date, Y., Murakami, N., Toshinai, K., Matsukura, S., Niijima, A., Matsuo, H., Kangawa, K. & Nakazato, M. (2002) The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology, 123, 1120-1128.
17. Edholm, O.G. (1977) Energy balance in man studies carried out by the Division of Human Physiology, National Institute for Medical Research. Journal of Human Nutrition, 31, 413-431.
18. Egan, J.M., Clocquet, A.R. & Elahi, D. (2002) The insulinotropic effect of acute exendin-4 administered to humans: comparison of nondiabetic state to type 2 diabetes. Journal of Clinical Endocrinology and Metabolism, 87, 1282-1290.
19. Farooqi, I.S., Yeo, G.S., Keogh, J.M., Aminian, S., Jebb, S.A., Butler, G., Cheetham, T. & O'Rahilly, S. (2000) Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. Journal of Clinical Investigations, 106, 271-279.
20. Farooqi, I.S., Matarese, G., Lord, G.M., Keogh, J.M., Lawrence, E., Agwu, C., Sanna, V., Jebb, S.A., Perna, F., Fontana, S., Lechler, R.I., DePaoli, A.M. & O'Rahilly, S. (2002) Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. Journal of Clinical Investigations 110, 1093-1103.
21. Fehm, H.L., Smolnik, R., Kern, W., McGregor, G.P., Bickel, U. & Born, J. (2001) The melanocortin melanocyte-stimulating hormone/adrenocorticotropin (4-10) decreases body fat in humans. Journal of Clinical Endocrinology and Metabolism, 86, 1144-1148.
22. Frandsen, J., Pedersen, S.B. & Richelsen, B. (1998) Long-term follow-up of patients who underwent jejunoileal bypass for morbid obesity. European Journal of Surgery, 164, 281-286.
23. Friedman, J.M. & Halaas, J.L. (1998) Leptin and the regulation of body weight in mammals. Nature, 395, 763-770.
24. Gibbs, J., Young, R.C. & Smith, G.P. (1973) Cholecystokinin decreases food intake in rats. Journal of Computer Physiological Psychology, 84, 488-495.
25. Goldstone, A.P., Unmehopa, U.A., Bloom, S.R. & Swaab, D.F. (2002) Hypothalamic NPY and agouti-related protein are increased in human illness but not in Prader-Willi syndrome and other obese subjects. Journal of Clinical Endocrinology and Metabolism, 87, 927-937.
26. Grandt, D., Schimiczek, M., Beglinger, C., Layer, P., Goebell, H., Eysselein, V.E. & Reeve, J.R. Jr (1994) Two molecular forms of peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1-36 and PYY 3-36. Regulatory Peptides, 51, 151-159.
27. Grill, H.J. & Smith, G.P. (1988) Cholecystokinin decreases sucrose intake in chronic decerebrate rats. American Journal of Physiology, 254, R853-R856.
28. Health Survey for England. (2001) http://www.doh.gov.uk/stats/tables/ trendtab06.xls. 2001.
29. Huszar, D., Lynch, C.A., Fairchild-Huntress, V., Dunmore, J.H., Fang, Q., Berkemeier, L.R., Gu, W., Kesterson, R.A., Boston, B.A. Cone, R.D. Smith, F.J. Campfield, L.A. Burn, P. & Lee, F. (1997) Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell, 88, 131-141.
30. James, W.P. Astrup, A. Finer, N. Hilsted, J. Kopelman, P. Rossner, S. Saris, W.H. & Van Gaal, L.F. (2000) Effect of sibutramine on weight maintenance after weight loss: a randomised trial. STORM Study Group. Sibutramine Trial of Obesity Reduction and Maintenance. Lancet, 356, 2119-2125.
31. Kalra, S.P. Dube, M.G. Pu, S. Xu, B. Horvath, T.L. & Kalra, P.S. (1999) Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocrine Review, 20, 68-100.
32. Kennedy, G.C. (1953) The role of depot fat in the hypothalamic control of food intake in the rat. Proceedings of the Royal Society of London B, 140, 579-592.
33. Kojima, M., Hosoda, H., Date, Y. Nakazato, M. Matsuo, H. & Kangawa, K. (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature, 402, 656-660.
34. Kolaczynski, J.W. Ohannesian, J.P. Considine, R.V. Marco, C.C. & Caro, J.F. (1996) Response of leptin to short-term and prolonged over-feeding in humans. Journal of Clinical Endocrinology and Metabolism, 81, 4162-4165.
35. Kopelman, P.G. (2000) Obesity as a medical problem. Nature, 404, 635-643.
36. Kreymann, B. Williams, G. Ghatei, M.A. & Bloom, S.R. (1987) Glucagon-like peptide-1, 7-36: a physiological incretin in man. Lancet, 2, 1300-1304.
37. Lord, G.M. Matarese, G. Howard, J.K. Baker, R.J. Bloom, S.R. & Lechler, R.I. (1998) Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature, 394, 897-901.
38. Mantzoros, C.S. & Flier, J.S. (2000) Editorial: leptin as a therapeutic agent - trials and tribulations. Journal of Clinical Endocrinology and Metabolism, 85, 4000-4002.
39. Matson, C.A. Wiater, M.F. Kuijper, J.L. & Weigle, D.S. (1997) Synergy between leptin and cholecystokinin (CCK) to control daily caloric intake. Peptides, 18, 1275-1278.
40. Mitchell, J.E. Lancaster, K.L. Burgard, M.A. Howell, L.M. Krahn, D.D. Crosby, R.D. Wonderlich, S.A. & Gosnell, B.A. (2001) Long-term follow-up of patients' status after gastric bypass. Obesity Surgery, 11, 464-468.
41. Moran, T.H. (2000) Cholecystokinin and satiety: current perspectives. Nutrition, 16, 858-865.
42. Nakazato, M. Murakami, N. Date, Y. Kojima, M. Matsuo, H. Kangawa, K. & Matsukura, S. (2001) A role for ghrelin in the central regulation of feeding. Nature, 409, 194-198.
43. NICE. (2001) Guidance of the use of Sibutramine for the Treatment of Obesity in Adults. Technology Appraisal Guidance - No 31. National Institute for Clinical Excellence, London
44. Rossi, M., Kim, M.S., Morgan, D.G., Small, C.J., Edwards, C.M., Sunter, D., Abusnana, S., Goldstone, A.P., Russell, S.H., Stanley, S.A., Smith, D.M., Yagaloff, K., Ghatei, M.A. & Bloom, S.R. (1998) A C-terminal fragment of Agouti-related protein increases feeding and antagonizes the effect of α-melanocyte stimulating hormone in vivo. Endocrinology, 139, 4428-4431.
45. Savage, A.P., Gornacz, G.E., Adrian, T.E., Ghatei, M.A., Goodlad, R.A., Wright, N.A. & Bloom, S.R. (1985) Is raised plasma peptide YY after intestinal resection in the rat responsible for the trophic response? Gut, 26, 1353-1358.
46. Sinha, M.K., Ohannesian, J.P., Heiman, M.L., Kriauciunas, A., Stephens, T.W., Magosin, S., Marco, C. & Caro, J.F. (1996) Nocturnal rise of leptin in lean, obese, and non-insulin-dependent diabetes mellitus subjects. Journal of Clinical Investigations, 97, 1344-1347.
47. Small, C.J., Kim, M.S., Stanley, S.A., Mitchell, J.R., Murphy, K., Morgan, D.G., Ghatei, M.A. & Bloom, S.R. (2001) Effects of chronic central nervous system administration of Agouti-related protein in pair-fed animals. Diabetes, 50, 248-254.
48. Tecott, L.H., Sun, L.M., Akana, S.F., Strack, A.M., Lowenstein, D.H., Dallman, M.F. & Julius, D. (1995) Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors. Nature, 374, 542-546.
49. Todd, J.F., Wilding, J.P., Edwards, C.M., Khan, F.A., Ghatei, M.A. & Bloom, S.R. (1997) Glucagon-like peptide-1 (GLP-1): a trial of treatment in non-insulin-dependent diabetes mellitus. European Journal of Clinical Investigations, 27, 533-536.
50. Tschop, M., Smiley, D.L. & Heiman, M.L. (2000) Ghrelin induces adiposity in rodents. Nature, 407, 908-913.
51. Tschop, M., Weyer, C., Tataranni, P.A., Devanarayan, V., Ravussin, E. & Heiman, M.L. (2001) Circulating ghrelin levels are decreased in human obesity. Diabetes, 50, 707-709.
52. Turton, M.D., O'Shea, D., Gunn, I., Beak, S.A., Edwards, C.M., Meeran, K., Choi, S.J., Taylor, G.M., Heath, M.M., Lambert, P.D., Wilding, J.P., Smith, D.M., Ghatei, M.A., Herbert, J. & Bloom, S.R. (1996) A role for glucagon-like peptide-1 in the central regulation of feeding. Nature, 379, 69-72.
53. Verdich, C., Flint, A., Gutzwiller, J.P., Naslund, E., Beglinger, C., Hellstrom, P.M., Long, S.J., Morgan, L.M., Holst, J.J. & Astrup, A. (2001) A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans. Journal of Clinical Endocrinology and Metabolism, 86, 4382-4389.
54. West, D.B., Greenwood, M.R., Marshall, K.A. & Woods, S.C. (1987) Lithium chloride, cholecystokinin and meal patterns: evidence that cholecystokinin suppresses meal size in rats without causing malaise. Appetite, 8, 221-227.
55. Williams, G., Bing, C., Cai, X.J., Harrold, J.A., King, P.J. & Liu, X.H. (2001) The hypothalamus and the control of energy homeostasis: different circuits, different purposes. Physiological Behavior, 74, 683-701.
56. Wren, A.M., Small, C.J., Ward, H.L., Murphy, K.G., Dakin, C.L., Taheri, S., Kennedy, A.R., Roberts, G.H., Morgan, D.G., Ghatei, M.A. & Bloom, S.R. (2000) The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology, 141, 4325-4328.
57. Wren, A.M., Seal, L.J., Cohen, M.A., Brynes, A.E., Frost, G.S., Murphy, K.G., Dhillo, W.S., Ghatei, M.A. & Bloom, S.R. (2001) Ghrelin enhances appetite and increases food intake in humans. Journal of Clinical Endocrinology and Metabolism, 86, 5992.
58. Yanovski, S.Z. & Yanovski, J.A. (2002) Obesity. New England Journal of Medicine, 346, 591-602.
59. Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L. & Friedman, J.M. (1994) Positional cloning of the mouse obese gene and its human homologue. Nature, 372, 425-432.